FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ensure drug safety and ...

The post RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.

Millions of Americans have increasingly turned to GLP-1 medications to lose weight and improve their health. These drugs have ...

Compounded GLP-1 medications help fill a necessary gap, but can have significant safety issues. Compounded GLP-1 medications ...

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the ...

FDA may let compounding pharmacies sell injectable peptides again amid safety concerns and RFK Jr. support. Read more here.

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

SteraMist iHP Expansion into Compounding 503A and 503B PharmaciesFREDERICK, Md., April 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in ...

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...

Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...

U.S. Compounding Pharmacy Market · GlobeNewswire Inc. Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "U.S. Compounding Pharmacy Market - Industry Outlook & Forecast 2024-2029" report has been added to ...